Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-03-31A Phase IV Study to Assess the Effect of Naltrexone Hydrochloride Extended Release (ER) and Bupropion Hydrochloride ER Combination (Contrave®/Mysimba®) on the Occurrence of Major Adverse Cardiovascular Events
-
CLINICAL_TRIALS study record update · 2026-03-31Metformin for Antipsychotic-induced Weight Gain in Adults With Intellectual Disability: A Double-Blind Randomized Control Trial
-
CLINICAL_TRIALS study record update · 2026-03-31Inter-relationships Among Iron Stores, the Gut Metagenome, Glucose Levels, and Different Cognitive Domains: the Role of Circulating MicroRNAs (IRONmiRNA Study).
-
CLINICAL_TRIALS study record update · 2026-03-31Impact of Lactobacillus Gasseri on Weight Management and Endocrine Function in Overweight Women: A Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2026-03-31Efficacy and Safety of NNC0487-0111 s.c. Once Weekly in Participants With Obesity Who Have Reached Target Dose During run-in Period (AMAZE 12)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-03-31Long-term Effectiveness of the Antiobesity Medication Phentermine
-
CLINICAL_TRIALS study record update · 2026-03-31Adipose Tissue Gene Expression and Metabolomics Links to the Gut Microbiome-brain Axis (POINSETTIA Study)
-
CLINICAL_TRIALS study record update · 2026-03-31Investigation of Pharmacokinetics, Safety and Tolerability of Multiple Subcutaneous Doses of NNC0519-0130 in Male Chinese Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-31Natural History of Type 2 Diabetes Mellitus in Children and Young Adults
-
CLINICAL_TRIALS study record update · 2026-03-31Diet Order Effects of Low Fat vs. Low Carb Diets on Body Fat Change
-
CLINICAL_TRIALS study record update · 2026-03-31Study of Short-Term Metabolic Adaptation: Prediction of Weight Change and Effects of Macronutrient Manipulations
-
CLINICAL_TRIALS study record update · 2026-03-31Non-invasive Blood Tests for the Diagnosis and Therapeutic Monitoring of Non-alcoholic Steato-hepatitis
-
CLINICAL_TRIALS study record update · 2026-03-31Integrated Analysis of the Interactions Between Glycemia and Microbiota Composition, and Their Impact on Brain Iron Deposition and Cognition in Subjects With Obesity
-
CLINICAL_TRIALS study record update · 2026-03-31A Prospective Consortium Evaluating the Long-term Follow-up of Patients With Type 2 Diabetes Enrolled In a Randomized Controlled Trial Comparing Bariatric Surgery Versus Medical Management
-
CLINICAL_TRIALS study record update · 2026-03-31Involvement of the Gut Microbiota-brain Cross-talk in the Loss of Eating Control (GMBCrossTalkFood)
-
CLINICAL_TRIALS study record update · 2026-03-30A Randomized Trial of Behaviorally Designed Gamification and Social Incentives to Increase Physical Activity Among Overweight and Obese Veterans
-
CLINICAL_TRIALS study record update · 2026-03-30A Phase I, Single-center, Open-Label, Single-Arm, Fixed-Sequence Study to Evaluate the Influence of HDM1005 on Gastric Emptying and Drug-Drug Interaction of HDM1005 and Metformin, Atorvastatin, Warfarin, and Digoxin in Overweight/Obese Adult Chinese Subjects
-
CLINICAL_TRIALS study record update · 2026-03-30Identifying Risk for Diabetes and Heart Disease in Women: A Study of African-American, African and White Federal Employees and Contractors
-
CLINICAL_TRIALS study record update · 2026-03-30Efficacy and Safety of Cagrilintide s.c. 2.4 Milligram (mg) in Combination With Semaglutide Subcutaneous (s.c). 2.4 mg (CagriSema s.c. 2.4 mg/2.4 mg) Once-weekly in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30A Pilot Study to Determine Tolerability to Glucagon Infusion in Obese Subjects
-
CLINICAL_TRIALS study record update · 2026-03-30Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation in Both Skeletal Muscle and Adipose Tissue
-
CLINICAL_TRIALS study record update · 2026-03-30Examining the Utility of GLP-1 Agonists as Neuroprotective Agents Through a Pilot Clinical Trial in High Risk Population With Neurocognitive Deficits and Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30Effect of Prolonged (72 Hour) Glucagon Administration on Energy Expenditure in Healthy Obese Subjects
-
CLINICAL_TRIALS study record update · 2026-03-30Efficacy and Safety of Cagrilintide s.c. in Combination With Semaglutide s.c.(CagriSema s.c. 1.0 mg/1.0 mg and 1.7 mg/1.7 mg) Once-weekly in Participants With Overweight or Obesity
-
CLINICAL_TRIALS study record update · 2026-03-30Effect of Body Vibration Sessions on Energy Expenditure at Rest and on Cardiovascular and Musculoskeletal Parameters in Obese Boys Hospitalized for a Multidisciplinary Program of Integrated Metabolic Rehabilitation